NuvaRing is a monthly method of combined hormonal contraception that consists of a thin and flexible ring that is inserted into the vagina. Each ring releases hormones (an oestrogen and a progestogen) gradually and is intended for one use only. Once inserted, the ring is left in place for 3 weeks before removal and there is a 1-week gap before a new ring is used.
This website contains product information and resources for UK healthcare professionals. The website also contains general information for women who have been prescribed NuvaRing.
Please note that you should consult your doctor or another suitably trained healthcare provider when considering what type of contraception is most appropriate for you.
If you have already been prescribed NuvaRing by your healthcare provider, you can find out more about how to use NuvaRing and sign up for a free SMS text messaging reminder service by clicking here.
Adverse events should be reported.
Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Merck Sharp & Dohme Ltd on 01992 467272